Severe ascites: Efficacy of the transjugular intrahepatic portosystemic shunt in treatment

Radiology

Volumn 200, Issue 1, 1996, Pages 185-192

  B Crenshaw, William ^a,b   Gordon, Fredric D ^a   McEniff, Niall J ^a   Perry, Laura J ^a   Hartnell, George ^a   Anastopoulos, Harry ^a   Jenkins, Roger L ^a   Lewis, W David ^a   Wheeler, Hugh G ^a   Clouse, Melvin E ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

Hepatic veins; Liver, cirrhosis; Liver, interventional procedure

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES; FEMALE; HEPATIC VEIN; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PARACENTESIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; SURVIVAL; SURVIVAL RATE;

EID: 15844411097     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.200.1.8657908     Document Type: Article

References (44)

1. Runyon BA, Hoefs JC, Morgan TR. Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988; 8:1104-1109.
2. Stanley MM, Ochi S, Lee KK, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989; 321:1632-1638.
3. Arroyo V, Epstein M, Gallu G, et al. Refractory ascites in cirrhosis: mechanisms and treatment. Gastroenterol Int 1989; 2:195-207.
4. Bories P, Garcia-Compean D, Michel H, et al. The treatment of refractory ascites by the LeVeen shunt: a multicenter controlled trial (57) patients. J Hepatol 1986; 3:212-218.
5. Runyon BA. Refractory ascites. Semin Liver Dis 1993; 13:343-351.
6. Richter GM, Noeldge G, Palmaz JC, et al. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology 1990; 174:1027-1030.
7. Kerlan RK, LaBerge JM, Gordon RL, Ring E. Transjugular intrahepatic portosystemic shunts: current status. AJR 1995; 164: 1059-1066.
8. LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with Wallstent endoprosthesis: results in 100 patients. Radiology 1993; 187:413-420.
9. Longmire-Cook SJ. Pathophysiologic factors and management of ascites. Gynecol Obstet 1993; 176:191-202.
10. Stassen WN, McCullough AJ. Management of ascites. Semin Liver Dis 1985; 5:291-307.
11. Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol 1993; 88:514-519.
12. Olafsson S, Blei AT. Diagnosis and management of ascites in the age of TIPS. AJR 1995; 165:9-15.
13. Witte MH, Witte CL, Dumont AE. Progress in liver disease: physiological factors involved in the causation of cirrhotic ascites. Gastroenterology 1971; 61:742-750.
14. Lieberman FL, Denison EK, Reynolds TB. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: the overflow theory of ascites formation. Ann NY Acad Sci 1970; 70:202-206.
15. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8:1151-1157.
16. Gines P, Arroyo V, Vargas V, et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med 1991; 325:829-835.
17. Gines P, Arroyo V, Quintero E, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites: results of a randomized study. Gastroenterology 1987; 93:234-241.
18. Gines P, Tito L, Arroyo V. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988; 94:1493-1502.
19. Smart HL, Triger DR. A randomized prospective trial comparing daily paracentesis and intravenous albumin with recirculation in diuretic refractory ascites. J Hepatol 1990; 10:191-197.
20. Salerno F, Badalamenti S, Lorenzano E, Moser P, Incerti P. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites. Hepatology 1991; 13:707-713.
21. Reynolds TB. Renaissance of paracentesis in the treatment of ascites. Adv Intern Med 1990; 35:365-374.
22. Schiff ER. Paracentesis: a safe and effective form of therapy. Hepatology 1987; 7:591-592.
23. Samanta AK, Leevy CM. Effect of peritoneovenous shunt on portal pressure. Gut 1989; 30:86-89.
24. Greig PD, Langer B, Blendis LM, Taylor BR, Glynn MFX. Complications after perito-neovenous shunting for ascites. Am J Surg 1980; 139:125-131.
25. Franco D, Vons C, Traynor O, de Smadja C. Should portosystemic shunt be reconsidered in the treatment of intractable ascites. Arch Surg 1988; 123:987-991.
26. Fulenwider JT, Galambos JD, Smith RB, et al. LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis: a randomized prospective trial. Arch Surg 1986; 121:351-355.
27. Shiffman ML, et al. Presented at the National Digestive Disease Advisory Board Conference, February 1994.
28. Rossle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stentshunt procedure for variceal bleeding. N Engl J Med 1994; 330:165-171.
29. LaBerge JM, Somberg KA, Lake JR, et al. Two-year outcome following transjugular intrahepatic portosystemic shunt for variceal bleeding: results in 90 patients. Gastroenterology 1995; 108:1143-1151.
30. Ochs A, Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stentshunt procedure for refractory ascites. N Engl J Med 1995; 332:1192-1197.
31. Ferrai H, Bjarnason H, Wegryn SA, et al. Refractory ascites: early experience in treatment with transjugular intrahepatic portosystemic shunt. Radiology 1993; 189: 795-801.
32. Quiroga J, Sangro B, Nunez M, et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites: effect on clinical, renal, humoral, and hemodynamic parameters. Hepatology 1995; 21: 986-994.
33. Pomier-Layrargues G, Legault L, Roy L, et al. TIPS for treatment of refractory ascites: a pilot study (abstr). Hepatology 1993; 18:103.
34. Ochs A, Sellinger M, Haag K, et al. Transjugular intrahepatic portosystemic stentshunt (TIPS) in the treatment of Budd-Chiari syndrome. J Hepatol 1993; 18:217-225.
35. Somberg KA, Lake JR, Tomlanovich SJ, LaBerge JM, Feldstein V, Bass NM. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function. Hepatology 1995; 3:709-716.
36. Lake JR, Ring E, LaBerge J, Gordon R, Roberts J, Ascher N. Transjugular intrahepatic portacaval stent shunts in patients with renal insufficiency. Transplant Proc 1993; 25:1766-1777.
37. Arroyo V, Gines P, Plannas R, Panes J, Rodes J. Management of patients with cirrhosis and ascites. Semin Liver Dis 1986; 6:353-369.
38. Martin M, Zaiko AB, Orons PD, et al. Transjugular intrahepatic portosystemic shunt in the management of variceal bleeding: indications and clinical results. Surgery 1993; 114:719-727.
39. Helton WS, Belshaw A, Althaus S, Park S, Coldwell D, Johansen K. Critical appraisal of the angiographic portacaval shunt (TIPS). Am J Surg 1993; 165:566-571.
40. Rosch J. Current status of TIPS: results and issues related to restenosis. Presented at the Seventh Annual International Symposium on Vascular Diagnosis and Inter-vention, Miami, Fla, January 21-25, 1995.
41. Almadal TP, Skinhoj P. Spontaneous bacterial peritonitis in cirrhosis: incidence, diagnosis and prognosis. Scand J Gastroenterol 1987; 22:295-300.
42. Tito L, Rimola A, Gines P, Lach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8:27-31.
43. Foschager MC, Ferrai H, Nazarian GK, Castaneda-Zuniga WR, Letourneau JG. Duplex sonography after transjugular intrahepatic portosystemic shunts (TIPS): normal hemodynamic findings and efficacy in predicting shunt patency and stenosis. AJR 1995; 165:1-7.
44. Dimagno EP, Zinsmeister FR, Larson DE, et al. Influence of hepatic reserve and cause of esophageal varices on survival and rebleeding before and after introduction of sclerotherapy: a retrospective analysis. Mayo Clin Proc 1985; 60:149-157.